FDA Distinguishes Pre-Market Expectations For Professional Vs. Home Glucose Meters
This article was originally published in The Gray Sheet
Executive Summary
The agency for the first time issued distinct guidance documents for blood glucose meters used in professional settings and those issued over-the-counter for self-monitoring tests by lay-persons. FDA is collecting comments on draft versions of the guidelines.
You may also be interested in...
FDA Extends Comment Period For Glucose Monitor Guidelines
The agency is giving product developers and others an additional month to comment on draft guidelines, issued in January, that distinguish pre-market requirements for glucose meters employed in professional health care settings from those intended for self-monitoring by patients.
Digital Health And Reimbursement Issues Divide Glucose Monitoring Market
Innovative technology from companies such as Google offers the promise of new digital health options in the glucose monitoring market, while drastic reimbursement cuts affecting existing meters and supplies in the US are taking a noticeable toll on the major players already operating in the field. These competing factors have created a dichotomy characterized by opportunity on one side and uncertainly on the other, and that is forcing some competitors to re-think their business strategies.
Survey Finds Competitive Bidding Restricts Access To Diabetes Products
The American Association of Diabetes Educators surveyed suppliers participating in the nationwide competitive bidding system for mail-ordered diabetes testing systems and found that they are not offering access to as many brands as they initially promised in their bids.